Very early researchActive Not RecruitingNCT05651178
What this trial is testing
Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients
Who this might be right for
Central Nervous System Lymphoma
Hrain Biotechnology Co., Ltd. 10